Chikara Kunisaki
Yokohama, Kanagawa, 232-0024, Japan
NCT Number: NCT01170845
A neutrophil elastase inhibitor may have effect on suppression of the lung injury after thoransthoracic esophagectomy. The investigators hypothesized that postoperative complication, particularly respiratory complication may be reduced by neutrophil elastase inhibitor after esophagectomy.
Looking for future studies?
Notify Me55 year–77 year
All sexes
Interventional
Not applicable
Yokohama, Kanagawa, 232-0024, Japan
The aim of this study was to clarify the usefulness of perioperative administration of sivelestat sodium hydrate, a selective inhibitor of neutrophil elastase in the pulmonary function, systemic inflammatory response, and the postoperative clinical course following video-assisted thoracoscopic esohpagectomy for esophageal cancer.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
saline or sivelestat sodium hydrate intravenously for 7 days starting the beginning of surgery
Other names: Elaspol
Time frame: 9 days
the arterial oxygen pressure
Time frame: 9 days
fraction of inspired oxygen ratio (PF ratio)
Time frame: 9 days
the duration of mechanical ventilation
Yokohama City University Medical Center
Other
A Pilot Study of Effect of Neutrophil Elastase Inhibitor on Lung Injury After Esophagectomy
Acronym: NEIE
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT00183898
Digestive System Diseases, Digestive System Neoplasms
Los Angeles, California, United States
View Trial DetailsNCT00341276
Digestive System Diseases, Digestive System Neoplasms
Taiyuan, China
View Trial DetailsNCT00342654
Digestive System Diseases, Digestive System Neoplasms
Beijing, China
View Trial DetailsNCT05538195
Colon Cancer, Colonic Diseases
Henan, China
View Trial Details